Pappas Arthur M

Avg. Two Year Performance

(95%) Avg. Purchase Return
(40%) Compound
(105%) Avg. Sale Return
(43%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(8%)(5%)(80%)(95%)
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return(< 1%)(23%)(23%)(89%)(105%)
Sale Success Rate1 of 20 of 21 of 21 of 21 of 2

Colucid Pharmaceuticals, Inc.

Drugs » Biotechnology

Director, 10% Owner:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Atherogenics Inc.

Drugs » Drug Manufacturers - Other

Director:

Holdings: 15.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Chimerix, Inc.

Drugs » Biotechnology

Director:

Holdings: 830.7K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Kezar Life Sciences, Inc.

Other » Other

10% Owner:

Holdings: 314.82K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Liquidia Technologies Inc

Other » Other

10% Owner:

Holdings: 480.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--